Business · 27/09/2001Updated: 10/17/2026 · 1 min read
FDA Determines Regulatory Review Period for TNKase Patent Extension
Summary
The Food and Drug Administration has officially confirmed the review period for TNKase, a human biological product patent extension application submitted to the US Patent and Trademark Office, as required by law.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →